Migraine Research - Send an Email Today to Increase Funding!

Teri Robert @trobert Health Guide
  • There's no question that we need better Migraine and headache treatments. With all the breakthroughs in treating other diseases and conditions, there's no excuse for the lack of effective treatment for Migraines and headaches.


    Did you know that there isn't a single medication available for Migraine and headache treatment that was actually developed for that purpose? Not one.


    One of the biggest problems is lack of research funding. Breakthroughs in treatment cannot be made until basic research into Migraine disease and other headache disorders is done. How can we expect researchers to develop treatments when we know so little about these conditions? What causes them? What are the genetics behind them? What goes on in the brain during a Migraine or headache? This is the kind of research that must be funded by the NIH. Migraine disease alone impacts 12% of the U.S. population, yet less than 1/10 of 1% of the NIH budget goes to Migraine and headache research.

    Add This Infographic to Your Website or Blog With This Code:


    We're making progress, but we have to keep pushing forward. Senator Patrick Leahy and Representative Peter Welch have written a letter about this to Dr. Francis Collins, the Director of the NIH. For this letter to be effective, we need other Senators and Representatives to co-sign it. PLEASE, click the "Take Action" link below to email your Senators and Representative, asking them to co-sign the letter. A beginning and ending for the email has been written for you. There's an open section for you to add a personal paragraph.


    Sending these emails can be done in literally less than 10 minutes. You don't have to know the email addresses to send them to. Once you've entered your name and mailing address, the system will automatically email them for you.


    Please, won't you take a few minutes to take action?


    Take Action. Now!
     
     
    Please Email Your Senators and Representative Now.
     
    Please Email Your Senators and Representative to Co-Sign a Vital Letter
    We're making progress. Let's keep it going!
     
    As a direct consequence of AHDA advocacy efforts, the NIH will be convening a major conference on May 16th and 17th that they state is intended to "develop a long-term strategy to support and promote headache research and develop Headache Disorder Research Benchmarks."  We hope and expect that the outcomes of this workshop will bring major new NIH funded research programs that will transform the field of headache medicine and markedly improve the prospects for tens of millions of sufferers.

    In order to assure that the proceedings and recommendations that emerge from the May conference are taken seriously and followed-up with substantial funded programs, Senator Patrick Leahy (VT) and Representative Peter Welch (VT) have drafted a letter (click here) of firm support to Dr. Francis Collins, the Director of NIH, which will be copied to the Honorable Kathleen Sebelius, the Secretary of Health and Human Services.

    Senator Leahy and Representative Welch are very eager to have as many other Members of Congress co-sign this letter as possible in order to send the strongest possible message that headache research must become a major NIH priority. We are asking that you contact your Senators and Representatives as soon as possible through the AHDA Action Center to ask them to co-sign this letter. We encourage you to add a few words to our message that can express to your Members of Congress what better therapy for migraine and other headache disorders would mean to you. With only a few mouse clicks you really can make a significant difference.
     
    Please join us now.
     
    Thank you,
    Bob Shapiro, AHDA President
    Bill Young, AHDA Vice President
    Brad Klein, ANDA Treasurer
    Teri Robert, AHDA Secretary
     



  • Live well,

    Add This Infographic to Your Website or Blog With This Code:



    Follow me on    or 





    Page copy protected against web site content infringement by Copyscape© Teri Robert, 2010
    Last updated April 8, 2010
Published On: April 08, 2010